Hasil Pencarian - Zengjun Li

  • Menampilkan 1 - 19 hasil dari 19
Perbaiki Hasil
  1. 1
    PB2428: CLINICAL EFFICACY AND HEALTH-RELATED QUALITY OF LIFE IN SEVERE APLASTIC ANEMIA TREATED BY UMBILICAL CORD BLOOD TRANSPLANTATION: A CROSS-SECTIONAL SURVEY IN CHINA

    PB2428: CLINICAL EFFICACY AND HEALTH-RELATED QUALITY OF LIFE IN SEVERE APLASTIC ANEMIA TREATED BY UMBILICAL CORD BLOOD TRANSPLANTATION: A CROSS-SECTIONAL SURVEY IN CHINA oleh Ping LI, Jun Peng, Zengjun LI

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A Healthy Dietary Pattern Reduces Lung Cancer Risk: A Systematic Review and Meta-Analysis

    A Healthy Dietary Pattern Reduces Lung Cancer Risk: A Systematic Review and Meta-Analysis oleh Yanlai Sun, Zhenxiang Li, Jianning Li, Zengjun Li, Jianjun Han

    Diterbitkan 2016-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test

    Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test oleh Lijie Xing, Hui Wang, Dan Liu, Qiang He, Zengjun Li

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    A nomogram for predicting the rapid progression of diffuse large B‐cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations

    A nomogram for predicting the rapid progression of diffuse large B‐cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 m... oleh Cong Liu, Pengyue Shi, Zhenjiang Li, Baosheng Li, Zengjun Li

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review

    Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review oleh Lijie Xing, Qiang He, Linna Xie, Hui Wang, Zengjun Li

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs

    Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs oleh Mingang He, Wenchao Gu, Yang Gao, Ying Liu, Jie Liu, Zengjun Li

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib

    Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib oleh Dan Liu, Lijie Xing, Hui Wang, Ping Li, Haichen Wei, Zengjun Li

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer

    Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer oleh Ling Wei, Jujie Sun, Nasha Zhang, Yue Shen, Teng Wang, Zengjun Li, Ming Yang

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Three-Dimensional Culture Decreases the Angiogenic Ability of Mouse Macrophages

    Three-Dimensional Culture Decreases the Angiogenic Ability of Mouse Macrophages oleh Haoxin Shi, Dong Li, Qing Shi, Zhenxia Han, Yuwei Tan, Xiaodong Mu, Miao Qin, Zengjun Li

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9

    Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9 oleh Yanlai Sun, Zhen Cao, Zhen Cao, Junqi Shan, Yang Gao, Xin Liu, Dejian Ma, Zengjun Li

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies

    Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies oleh Bo Jiang, Junyuan Qi, Yuqin Song, Zengjun Li, Meifeng Tu, Lingyan Ping, Zongliang Liu, Hanying Bao, Zusheng Xu, Lugui Qiu

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

    P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA oleh Xiyuan Zhang, Kang Chen, Hui Wang, Xiuizhi Deng, Guoqiang Liu, Junjie MA, Juan Wang, Xianghua Wang, Zhenhui LV, Zengjun LI, Ling Wang

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    PB2376: ASSAY DEVELOPMENT AND VALIDATION OF IG-HTS TO MONITOR MRD IN PLASMA OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

    PB2376: ASSAY DEVELOPMENT AND VALIDATION OF IG-HTS TO MONITOR MRD IN PLASMA OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) oleh Jinghua Wu, LI-Jie Xing, Fan Yang, Xiaoxia Wang, Shixin Lu, Shunjin Zhang, Sen Yin, Hai-Chen Wei, Zengjun LI, Xiao Liu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

    Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study oleh Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Jianfeng Zhou, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Meng Ji, Haiyi Guo, Jane Huang, William Novotny, Shibao Feng, Jianyong Li

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis

    Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis oleh Shuhua Yi, Yu Zhang, Wenjie Xiong, Weiwei Chen, Zhaohua Hou, Yang Yang, Yuting Yan, Yunbo Wei, Rui Cui, Huijun Wang, Zhen Yu, Heng Li, Zengjun Li, Wei Liu, Rui Lv, Tingyu Wang, Kun Ru, Dehui Zou, Minglei Shu, Lugui Qiu, Di Yu

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study

    The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study oleh Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor, Daobin Zhou

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The impact of response kinetics for multiple myeloma in the era of novel agents

    The impact of response kinetics for multiple myeloma in the era of novel agents oleh Yuting Yan, Xuehan Mao, Jiahui Liu, Huishou Fan, Chenxing Du, Zengjun Li, Shuhua Yi, Yan Xu, Rui Lv, Wei Liu, Shuhui Deng, Weiwei Sui, Qi Wang, Dehui Zou, Jianxiang Wang, Tao Cheng, Fenghuang Zhan, Yu-Tzu Tai, Chenglu Yuan, Xin Du, Lugui Qiu, Kenneth C. Anderson, Gang An

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    PB2272: PI3KΔ INHIBITOR LINPERLISIB FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL

    PB2272: PI3KΔ INHIBITOR LINPERLISIB FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL oleh Lihua Qiu, Tingyu Wang, Xiuhua Sun, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    PB2269: PI3KΔ INHIBITOR LINPERLISIB FOR ELDERLY PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL

    PB2269: PI3KΔ INHIBITOR LINPERLISIB FOR ELDERLY PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL oleh Xiuhua Sun, Tingyu Wang, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: